News Sentiment

VRTX34 sentiment intelligence

Vertex Pharmaceuticals Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 19 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 621.43 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 19

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-10.0% over one week, +10.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Vertex Pharmaceuticals stock hits 52-week high at $507.98

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -10.0% Price reacting lower
Trend fit Trend inactive 10.1% over four weeks
Fair value 6.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 10
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 19
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing.com 7
GuruFocus 3
Barchart.com 2
Investing.com Australia 2
IndexBox 2
timothysykes.com 1
Seeking Alpha 1
Fierce Pharma 1

Event Lens

What the news is about

Classified themes
Market update 11
Earnings 3
Analyst action 3
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-19 of 19